Secukinumab Looks Promising for Polymyalgia Rheumatica
Secukinumab Shows Promise for Polymyalgia Rheumatica A phase 3 trial has reported topline data on secukinumab for patients with polymyalgia rheumatica (PMR), a common inflammatory rheumati…
Secukinumab Shows Promise for Polymyalgia Rheumatica A phase 3 trial has reported topline data on secukinumab for patients with polymyalgia rheumatica (PMR), a common inflammatory rheumati…
Amazon Layoffs: Implications for HR Leaders Amazon is reportedly cutting up to 10% of its corporate staff, with 14,000 corporate workers l…
Supercell Shuts Down Squad Busters Supercell will end active development on Squad Busters and close the game in the latter half of 2026.
Mercy Sci-Fi Thriller Film Directed by Timur Bekmambetov, 'Mercy' is a science fiction thriller film that tells the story of a detective o…
Lululemon Closes West Highland Store Lululemon has closed its West Highland store after eight years of operation. The store, located at 34…
Danielle Smith: Balancing the Budget with Pipelines As part of the Financial Post's Red Ink series, Danielle Smith, Premier of Alberta, di…
Microsoft Brings Discovery AI Technology to NJ AI Hub Microsoft, a founding partner of the New Jersey Artificial Intelligence Hub (NJ AI H…
Sustainability Symposium at University of Wisconsin The University of Wisconsin Office of Sustainability hosted its fourth annual Sustaina…
MPC Holds Policy Rate at 26% as Inflation Pressures Persist The Reserve Bank of Malawi (RBM) has maintained the Policy Rate at 26.0 percen…
Funding, the COVID Inquiry and the Ten-Year Plan The BMA public health committee met to discuss various issues, including workforce and ch…
DCU Consortium Secures €2.3m Funding The DCU-led consortium, including HT Materials Science Ltd and Exergyn Ltd, has been awarded €2.3m fr…